Hanlon AL - Search Results

1

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. Trabulsi EJ, et al. Among authors: hanlon al. Urology. 2008 Dec;72(6):1298-302; discussion 1302-4. doi: 10.1016/j.urology.2008.05.057. Epub 2008 Jul 30. Urology. 2008. PMID: 18672274 Free PMC article.

2

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Horwitz EM, et al. Among authors: hanlon al. J Urol. 2003 Jun;169(6):2153-7; discussion 2157-9. doi: 10.1097/01.ju.0000067181.52741.09. J Urol. 2003. PMID: 12771738

3

Positive prostate biopsy laterality and implications for staging.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Buyyounouski MK, et al. Among authors: hanlon al. Urology. 2003 Aug;62(2):298-303. doi: 10.1016/s0090-4295(03)00334-0. Urology. 2003. PMID: 12893339

4

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Pollack A, et al. World J Urol. 2003 Sep;21(4):200-8. doi: 10.1007/s00345-003-0356-x. Epub 2003 Sep 5. World J Urol. 2003. PMID: 12961097 Review.

5

Does age matter in the selection of treatment for men with early-stage prostate cancer?

Konski A, Eisenberg D, Horwitz E, Hanlon A, Pollack A, Hanks G. Konski A, et al. Cancer. 2006 Jun 15;106(12):2598-602. doi: 10.1002/cncr.21923. Cancer. 2006. PMID: 16683224 Free article.

6

Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death.

Alcantara P, Hanlon A, Buyyounouski MK, Horwitz EM, Pollack A. Alcantara P, et al. Cancer. 2007 Jan 1;109(1):41-7. doi: 10.1002/cncr.22341. Cancer. 2007. PMID: 17133416 Free PMC article.

7

Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.

Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Greenberg RE, Stobbe C, Hanks GE, Pollack A. Movsas B, et al. Among authors: hanlon al. Urology. 2002 Oct;60(4):634-9. doi: 10.1016/s0090-4295(02)01858-7. Urology. 2002. PMID: 12385924

8

Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer.

Hanlon AL, Horwitz EM, Hanks GE, Pollack A. Hanlon AL, et al. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):43-52. doi: 10.1016/s0360-3016(03)01432-9. Int J Radiat Oncol Biol Phys. 2004. PMID: 14697419

9

The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer.

Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. Jacob R, et al. Among authors: hanlon al. Cancer. 2004 Feb 1;100(3):538-43. doi: 10.1002/cncr.11927. Cancer. 2004. PMID: 14745870 Free article.

10

Prostate cancer radiotherapy dose response: an update of the fox chase experience.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. Pollack A, et al. Among authors: hanlon al. J Urol. 2004 Mar;171(3):1132-6. doi: 10.1097/01.ju.0000111844.95024.74. J Urol. 2004. PMID: 14767286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page